(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(2-(methylthio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol

ID: ALA1651364

Chembl Id: CHEMBL1651364

PubChem CID: 14191021

Max Phase: Preclinical

Molecular Formula: C11H14N4O4S

Molecular Weight: 298.32

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: NSC-25740 | CHEMBL1651364|NSC-25740|BDBM50335309|Purine, 2-methylthio-9-beta-D-ribofuranosyl|(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(2-methylsulfanylpurin-9-yl)tetrahydrofuran-3,4-diol|(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(2-(methylthio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol

Canonical SMILES:  CSc1ncc2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1

Standard InChI:  InChI=1S/C11H14N4O4S/c1-20-11-12-2-5-9(14-11)15(4-13-5)10-8(18)7(17)6(3-16)19-10/h2,4,6-8,10,16-18H,3H2,1H3/t6-,7-,8-,10-/m1/s1

Standard InChI Key:  AQBXLSVGUYASIQ-FDDDBJFASA-N

Associated Targets(non-human)

ADA Adenosine deaminase (739 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rmlD dTDP-4-dehydrorhamnose reductase (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 298.32Molecular Weight (Monoisotopic): 298.0736AlogP: -0.84#Rotatable Bonds: 3
Polar Surface Area: 113.52Molecular Species: NEUTRALHBA: 9HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.45CX Basic pKa: 3.22CX LogP: -0.55CX LogD: -0.55
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.50Np Likeness Score: 0.42

References

1. Gillerman I, Fischer B..  (2011)  Investigations into the origin of the molecular recognition of several adenosine deaminase inhibitors.,  54  (1): [PMID:21138280] [10.1021/jm101286g]
2. Wang Y, Hess TN, Jones V, Zhou JZ, McNeil MR, Andrew McCammon J..  (2011)  Novel inhibitors of Mycobacterium tuberculosis dTDP-6-deoxy-L-lyxo-4-hexulose reductase (RmlD) identified by virtual screening.,  21  (23): [PMID:22014548] [10.1016/j.bmcl.2011.09.094]

Source